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K ikuchi-Fujimoto disease (KFD),  or histiocytic necrotizing lymphadenitis,  is an autoimmune,  
self-limiting lymphadenitis,  typically presenting as a 
persistent cervical lymphadenopathy accompanied by a 
fever.  Although a viral etiology has long been sug-
gested,  the disorder remains idiopathic [1,2].  The 
clinical characteristics of KFD resemble those of 
malignant lymphoma (ML),  and diﬀerentiating between 
the two is sometimes diﬃcult [3,4].  Reactive 
hemophagocytic lymphohistiocytosis (HLH) is a rare 
but life-threatening disease with various etiologies.  
Although ML occasionally induces HLH,  KFD is 
rarely diagnosed as a primary disease underlying 
HLH,  and the clinical features of HLH-associated 
KFD remain to be determined.  We describe the case 
of a 30-year-old Japanese man diagnosed with HLH-
associated KFD and present a literature review.
Case Presentation
　 A 30-year-old previously healthy Japanese man 
presented to our hospital with 2 weeks of high fever 
and a sore throat.  He had been treated with 500 mg 
Acta Med.  Okayama,  2016
Vol.  70,  No.  5,  pp.  383-388
CopyrightⒸ 2016 by Okayama University Medical School.
http ://escholarship.lib.okayama-u.ac.jp/amo/Case Report
Kikuchi-Fujimoto Disease Complicated with  
Reactive Hemophagocytic Lymphohistiocytosis
Masatake Nishiwakia＊,  Hideharu Hagiyab,  and Toru Kamiyaa, c
aDepartment of General Internal Medicine,  cDivision of Infectious Diseases,  Rakuwakai Otowa Hospital,  Kyoto 607-8062 Japan,   
bDivision of Infection Control and Prevention,  Osaka University Hospital,  Osaka 565-0871 Japan
Kikuchi-Fujimoto disease (KFD) is a benign cause of self-limiting subacute necrotizing lymphadenitis.  
KFD is rarely complicated with reactive hemophagocytic lymphohistiocytosis (HLH),  and the clinical 
features of the simultaneous occurrence of these conditions are uncertain.  A 30-year-old Japanese man 
with a persistent fever and sore throat presented to our hospital for treatment.  Laboratory analysis 
showed bicytopenia,  and radiological studies showed systemic lymphadenopathy accompanied by sple-
nomegaly.  A bone marrow examination showed hemophagocytic macrophages,  suggesting HLH.  
Malignant lymphoma was suspected as a possible underlying disease,  but the histology of the lymph 
nodes led to a ﬁnal diagnosis of KFD and treatment with prednisolone (1 mg/kg/day),  resulting in clin-
ical improvement.  This case highlighted the importance and diﬃculty of diﬀerentiating KFD from 
malignant lymphoma as an underlying condition of HLH.  The literature review showed that patients 
with HLH-associated KFD may have higher serum ferritin and lactate dehydrogenase levels compared 
to typical KFD cases.  Deﬁnite diagnosis based on pathological examination is essential for a better 
understanding of this rare disease.  The presence of systemic lymphadenopathy does not exclude the 
possibility of KFD.  This case serves to remind physicians that KFD is a potential etiology of HLH.
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per day of levoﬂoxacin for 5 days with no clinical 
improvement.  On admission,  he complained of chills,  
sore throat,  fatigue,  and anorexia.  He denied rigors,  
cough,  sputum,  rhinorrhea,  weight loss,  or night 
sweats.  The review of systems was otherwise unre-
markable.  On physical examination,  he had a tem-
perature of 39.5℃,  heart rate of 112 beats/min 
(regular),  blood pressure of 157/98 mmHg,  respira-
tory rate of 20 breaths/min,  and oxygen saturation of 
96  while breathing room air.  He appeared mildly 
distressed.  Physical examination revealed a non-ten-
der lymph node at the cervical and left axillary region,  
but was otherwise unremarkable.
　 His laboratory data showed bicytopenia (white 
blood cell count,  1,500/µL; neutrophils,  65 ; plate-
lets,  130,000/µL) and elevated lactate dehydrogenase 
(LDH 1,111 IU/L) and transaminase levels (AST 
128 IU/L; ALT 138 IU/L).  His triglyceride,  ferri-
tin,  and serum soluble interleukin-2 receptor levels 
were increased to 321 mg/dL,  1,730 ng/mL,  and 
1,210 U/mL,  respectively.  Serologic assays for 
Epstein-Barr virus (EBV) showed a past infection 
pattern (positive for viral capsid antigen (VCA)-IgG 
(1 : 20) and EBV nuclear antigen (EBNA) but negative 
for EBV VCA-IgM).  The EBV-DNA copy number in 
whole blood,  measured by real-time polymerase chain 
reaction (RT-PCR),  was not elevated.  Serologic tests 
for other common viral infections including human 
immunodeﬁciency virus (HIV),  cytomegalovirus,  par-
vovirus B19,  herpes simplex virus,  hepatitis A,  hep-
atitis B,  and hepatitis C did not suggest any acute 
infections.  Antinuclear antibody,  rheumatoid factor,  
and serum C3 and C4 levels were normal.  
Coagulation test results were almost normal.  A con-
trast-enhanced computed tomography (CT) scan 
revealed enlarged cervical,  para-aortic,  mesenteric,  
axillary lymph nodes on both sides and moderate sple-
nomegaly (Fig.  1).  For the evaluation of bicytopenia,  
bone marrow aspiration was performed.  The result 
showed hemophagocytic macrophages (Fig.  2),  and a 
diagnosis of HLH was conﬁrmed according to the 
384 Nishiwaki et al. Acta Med.  Okayama　Vol.  70,  No.  5
BA
C
S
D
Fig.  1　 Contrast-enhanced CT scan revealed enlarged lymph nodes at the para-aortic ((A),  12 mm),  mesenteric ((B),  13 mm),  and 
axillary regions ((C),  15 mm) (arrowheads),  as well as splenomegaly ((D),  12. 5 cm; indicated by S).
Fig.  2　 A bone marrow aspirate showed hemophagocytic macro-
phage engulﬁng neutrophils (blue arrow),  erythrocytes (red arrow),  
and platelets (black arrow) (MG-Giemsa staining).
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Fig. 3　 Left axillary lymph node biopsy showed a paracortical necrotizing zone (N) accompanied by apoptotic necrosis with abundant 
karyorrhectic debris and a large number of histiocytes, including a few crescentic histiocytes (arrowhead) (hematoxylin and eosin staining, 
(A, B)).
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Fig.  4　 Immunohistochemical study demonstrated a necrotizing zone with numerous CD3-positive T cells (CD3 immunostaining,  (A,  
B)) and few CD20-positive B cells (CD20 immunostaining,  (C,  D)).  CD68-positive histiocytes were noted in the necrotizing zone (CD68 
immunostaining,  (E)).
established clinical criteria [5].
　 The patient was initially treated with nonsteroidal 
anti-inﬂammatory drugs.  However,  the high fever 
persisted,  and a left axillary lymph node biopsy was 
performed for further investigation.  The histopatho-
logical examination showed typical ﬁndings of KFD 
(Fig.  3).  No hemophagocytosis,  granulomas,  caseous 
necrosis,  or evidence of malignancy was found.  
Immunohistochemical study showed that the necrotiz-
ing zone was inﬁltrated with numerous CD3-positive 
T cells.  Although there were few CD20-positive B 
cells observed in the lymph node,  CD68-positive his-
tiocytes were noted in the necrotizing zone (Fig.  4).  
Flow cytometry and cytogenetic analysis of the lymph 
node showed no evidence of lymphoma or leukemia.  
Based on these histopathological ﬁndings,  a deﬁnitive 
diagnosis of KFD was made.
　 Based on a ﬁnal diagnosis of HLH-associated KFD,  
treatment was started with 1 mg/kg prednisolone 
(60 mg) daily tapered over 3 weeks by 10 mg every 3 
days.  His condition steadily improved following the 
treatment,  and he was discharged on the 24th hospi-
tal day.  A follow-up CT scan after 3 months showed 
improvement of the generalized lymphadenopathy and 
splenomegaly.  The patient remains well after 6 
months,  without recurrence.
Discussion
　 KFD is typically a self-limiting disease that mani-
fests as a persistent fever and painful cervical lymph-
adenopathy.  Patients with HLH,  on the other hand,  
usually have underlying diseases and may follow a 
severe and fatal course.  According to a previous 
report summarizing 162 cases of HLH,  92 cases 
(56.8 ) were induced by hematologic malignancies,  
mainly non-Hodgkin lymphomas (lymphoma-associated 
hemophagocytic syndrome),  followed by infectious 
etiologies (24.4 ) [6].  Chemo-immunotherapy 
(etoposide,  corticosteroids,  cyclosporin A,  and,  in 
selected patients,  intrathecal methotrexate) has been 
given to patients with HLH [5].  The mortality rate 
has been reported to be as high as 20  [6].
　 HLH is rarely induced by KFD; however,  there 
are many possible overlaps in the etiology and clinical 
features between the 2 conditions.  A possible role of 
cytokines such as interferon-gamma and interleukin-6 
in the pathogenesis of KFD [7,8],  as well as HLH 
[9,10],  was suggested in previous studies.  These 2 
diseases may be parts of a continuum of a single clini-
cal condition,  rather than diﬀerent entities [11].
　 Due to the rarity of HLH-associated KFD,  its 
clinical characteristics are still not well understood.  
We therefore performed a literature review and sum-
marized 23 such cases including the present case 
(Table 1) [8-24].  The median age at diagnosis was 14 
years,  and the male-to-female ratio was 12 : 11.  
Almost all patients showed cytopenia and increased 
serum ferritin,  LDH,  and triglyceride levels.  The 
median serum ferritin and LDH levels (1,168 ng/mL 
and 1,238 IU/L,  respectively) were substantially 
higher in patients with HLH-associated KFD than in 
Japanese KFD patients without HLH (796 ng/mL and 
245 IU/L,  respectively) [4].  Complications of sple-
nomegaly and hepatomegaly are rarely seen in KFD 
(2  and 3 ,  respectively) [3],  but these conditions 
were observed in 12 (63 ) and 8 (42 ) cases of 
HLH-associated KFD,  respectively.  The high serum 
ferritin and LDH levels as well as organomegaly con-
stitute helpful criteria for diagnosing HLH [25].  In 
contrast to the benign course of KFD,  3 patients with 
HLH-associated KFD (13 ) died [16,21,22].  A pre-
viously healthy 5-year-old child was treated with a 
combination of etoposide and steroids,  but eventually 
died of serious pancytopenia [22].  The second fatal 
case was a 24-year-old postpartum woman who devel-
oped disseminated intravascular coagulation and adult 
respiratory distress syndrome.  Treatment with antibi-
otics,  high-dose intravenous immunoglobulin (IVIG) 
and acyclovir did not work,  and the authors empha-
sized the importance of the early diagnosis of HLH 
during pregnancy [16].  The third case was a 50-year-
old man with systemic lupus erythematosus who even-
tually died after treatment with corticosteroids and 
broad-spectrum antibiotics.  The importance of appro-
priate intensive immunosuppressive therapy was 
stressed [21].
　 HLH-associated KFD has a potentially fatal out-
come,  and early treatment is required.  In the 
reviewed cases,  the treatment included corticoste-
roids (19 cases),  IVIG (9 cases) and etoposide (5 
cases).  Among these,  corticosteroids can be consid-
ered an eﬀective ﬁrst-line treatment option for the 
disease; IVIG and etoposide could be alternative 
regimens.  
　 In our case,  the presence of systemic lymphade-
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nopathy confused us and made it diﬃcult to make a 
diagnosis of KFD.  Complication with systemic lymph-
adenopathy is rarely seen in KFD,  as it was observed 
in only 2 (2.9 ) of the 69 Japanese KFD cases [4].  
However,  a histological examination successfully dif-
ferentiated the disease from other etiologies and con-
tributed to the definite diagnosis of KFD.  
Importantly,  ML,  the most common etiology of HLH,  
was excluded based on the ﬁndings of immunohisto-
chemical staining and ﬂow cytometry.  Characteristic 
KFD histopathologic ﬁndings include irregular para-
cortical areas of coagulative necrosis with abundant 
karyorrhectic debris,  which can distort the nodal 
architecture.  Immunohistochemistry is also valuable 
in diagnosing KFD with a predominance of T-cells 
[26].
　 In conclusion,  we present a rare case of HLH-
associated KFD.  Our literature review revealed that 
higher levels of serum ferritin and LDH as well as 
hepatosplenomegaly were more frequently observed in 
patients with HLH-associated KFD than in typical 
KFD cases.  In contrast to the self-limiting course of 
KFD,  the prognosis of the patients with HLH-
associated KFD may be fatal.  A deﬁnite diagnosis 
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Table 1　 Summary of 23 cases of HLH-associated KFD
Case 
No.
Age/
Sex
Associated 
diseases Treatment Aﬀected LN Splenomegaly Hepatomegaly
WBC  
(/μL)
Hb  
(g/dL)
Plt  
(×104/μL)
Ferritin 
(ng/mL)
TG 
 (mg/dL)
LDH 
(IU/L) Outcome Ref
 1 17/F Unknown mPSL,  IVIG,  
ACV
C,  A,  I (＋) (－) 1,100  7.6  9.8   780 216 2,809 Improved 12
 2 15/F Infection  
(PVB19)
PSL C (＋) (＋) 1,400  7.5 14.7 2,500 NA 1,941 Improved 13
 3 15/F Unknown PSL C,  M (－) (－) 3,000 11.6 35.3   720 NA   337 Improved 8
 4 37/F SLE PSL/mPSL C,  A (－) (＋) 1,130 12.8 10.6 6,330 472 3,162 Improved 9
 5  6/M Infection  
(RSV),   
sickle cell
PSL/DEX,   
VP16,  CyA
C NA NA 3,200 12.4 23.8 35,500 NA 8,340 Improved 14
 6 10/F Unknown PSL,  IVIG C NA NA 1,400  9.7 21.9 1,083 207   852 Improved 15
 7 14/M Unknown PSL,  IVIG C (－) (＋) 1,450 12  9.8   128 146 1,238 Improved 15
 8 24/F Infection  
(EBV)
IVIG,  ACV C (＋) (＋) 2,600 NA  2.3 NA NA NA Died 16
 9 17/F Unknown IVIG C NA NA 3,100  9.9 Normal ＞1,000 NA 1,317 Improved 11
10  1/F JIA mPSL/PSL,  
IVIG,   
MTX,  CyA
Generalized (＋) (－) 4,100  5.8  8.9 41,500 362 NA Improved 17
11 13/F Unknown mPSL/DEX,  
IVIG,  VP16,
C (－) (－) 1,500 10.3  3.9 14,955 144 NA Improved 18
12  2/M JMML PSL NA (＋) (＋) NA Anemia  0.3   500 Raised NA Improved 19
13 40/M Unknown NSAIDs C (＋) (－) 2,700 13.2  8.2 NA 354 NA Improved 20
14 13/M Unknown PSL C,  I (＋) (＋) 1,700 NA 13.5 NA 306   417 Improved 10
15 50/M SLE mPSL C,  A,  I (＋) (－) 2,040  8.4  9.6 NA NA 3,056 Died 21
16 12/M Unknown PSL C NA NA 2,500 10.5 22 1,003  80 1,105 Improved 22
17 14/M Infection 
(EBV)
DEX,  IVIG,  
ACV,  VP16
C,  A,  I (－) (－) 3,200  9.1 16.9 2,541 177   682 Improved 22
18  5/F Unknown PSL/DEX,  
VP16
C,  A,  I,  P (＋) (＋) 1,800  6.7 11 3,371 377 1,540 Died 22
19 14/F Unknown DEX,  IVIG,  
VP16,  CyA
C (－) (－) 2,400  9.8 10.8   472  78   627 Improved 22
20  8/M Infection 
(EBV)
PSL C,  A,  I,  M (＋) (＋) 3,000 11.6 10.5 1,168 104 1,308 Improved 22
21 16/M Infection 
(EBV)
No medica-
tion
C, A (＋) (－) 1,240 12.6 13 892.9 275 NA Improved 23
22 21/M Sweetʼs 
syndrome
PSL C (－) (－) 2,000 11.8  5.8 Normal Normal   436 Improved 24
23 30/M Unknown PSL C,  A,  I,  P,   
M
(＋) (－) 1,500 12.5 13 1,730 197 1,111 Improved Ours
NA, not available; LN, lymph node; PVB19, Parvovirus B19; EBV, Epstein-Barr virus; RSV, Respiratory syncytial virus; JIA, Systemic juvenile idio-
pathic arthritis; JMML, Juvenile myelomonocytic leukemia; ANA, antinuclear antibodies; SLE, Systemic lupus erythematosus; ACV, Acyclovir; IVIG, 
intravenous immunoglobulin; NSAIDs, nonsteroidal anti-inﬂammatory drugs; DEX, Dexamethazone; VP16, Etoposide; MTX, Methotrexate; PSL, 
Prednisolone; mPSL, Methylprednisolone; CyA, Cyclosporine A. The aﬀected lymph nodes are described as follows: C, cervical; A, axillary; I, ingui-
nal; P, para-aortic; M, mesenteric. 
based on pathological examination is essential for a 
better understanding of this rare disease.  
Additionally,  physicians should not exclude KFD from 
the diﬀerential diagnosis of systemic lymphadenopa-
thy.
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